William Blair Has Pessimistic Outlook of NAMS Q1 Earnings
NewAmsterdam Pharma (NASDAQ:NAMS – Free Report) – Research analysts at William Blair dropped their Q1 2025 EPS estimates for shares of NewAmsterdam Pharma in a research report issued on Wednesday, February 26th. William Blair analyst M. Phipps now expects that the company will earn ($0.51) per share for the quarter, down from their previous forecast […]
NewAmsterdam Pharma (NASDAQ:NAMS – Free Report) – Research analysts at William Blair dropped their Q1 2025 EPS estimates for shares of NewAmsterdam Pharma in a research report issued on Wednesday, February 26th. William Blair analyst M. Phipps now expects that the company will earn ($0.51) per share for the quarter, down from their previous forecast […]
